• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺炎与良性前列腺增生症发生之间的纵向关联

Longitudinal association between prostatitis and development of benign prostatic hyperplasia.

作者信息

St Sauver Jennifer L, Jacobson Debra J, McGree Michaela E, Girman Cynthia J, Lieber Michael M, Jacobsen Steven J

出版信息

Urology. 2008 Mar;71(3):475-9; discussion 479. doi: 10.1016/j.urology.2007.11.155.

DOI:10.1016/j.urology.2007.11.155
PMID:18342190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2597174/
Abstract

OBJECTIVES

To determine whether physician-diagnosed prostatitis was associated with later development of benign prostatic hyperplasia (BPH)-associated events in a longitudinal, population-based sample of 2447 men residing in Olmsted County, Minnesota.

METHODS

Medical records were reviewed for physician diagnosis of prostatitis and subsequent diagnoses of BPH, enlarged prostate, prostatism, and acute urinary retention. Records were also reviewed for medical or surgical treatments for BPH. Odds ratios were calculated to assess the associations between physician-diagnosed prostatitis and later development of development of BPH-associated events.

RESULTS

Physician-diagnosed prostatitis was associated with a 2.4-fold increased odds of receiving a later diagnosis of prostatism, enlarged prostate, or BPH (OR: 2.44, 95% CI: 1.48, 4.01). Prostatitis was also associated with a 70% increased odds of requiring later treatment for BPH (OR: 1.69, 95% CI: 1.28, 2.22), and a non-significant increased odds of acute urinary retention (OR: 1.33, 95% CI: 0.89, 1.99).

CONCLUSIONS

Physician-diagnosed prostatitis was associated with an increased risk of later onset of several BPH-associated events. Physician-diagnosed prostatitis may therefore be an early marker or a risk factor for development of later prostatic or urologic problems.

摘要

目的

在明尼苏达州奥姆斯特德县居住的2447名男性的纵向、基于人群的样本中,确定医生诊断的前列腺炎是否与随后良性前列腺增生(BPH)相关事件的发生有关。

方法

回顾医疗记录,以了解医生对前列腺炎的诊断以及随后对BPH、前列腺肿大、前列腺增生和急性尿潴留的诊断。还回顾了BPH的药物或手术治疗记录。计算比值比以评估医生诊断的前列腺炎与随后BPH相关事件发生之间的关联。

结果

医生诊断的前列腺炎与随后被诊断为前列腺增生、前列腺肿大或BPH的几率增加2.4倍相关(比值比:2.44,95%置信区间:1.48,4.01)。前列腺炎还与随后需要进行BPH治疗的几率增加70%相关(比值比:1.69,95%置信区间:1.28,2.22),以及急性尿潴留的几率增加但不显著(比值比:1.33,95%置信区间:0.89,1.99)。

结论

医生诊断的前列腺炎与随后发生几种BPH相关事件的风险增加有关。因此,医生诊断的前列腺炎可能是后期前列腺或泌尿系统问题发生的早期标志物或危险因素。

相似文献

1
Longitudinal association between prostatitis and development of benign prostatic hyperplasia.前列腺炎与良性前列腺增生症发生之间的纵向关联
Urology. 2008 Mar;71(3):475-9; discussion 479. doi: 10.1016/j.urology.2007.11.155.
2
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.
3
Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.无尿潴留表现的良性前列腺增生或前列腺腺癌男性患者中组织学前列腺炎的患病率
S Afr J Surg. 2012 Nov 12;50(4):127-30. doi: 10.7196/sajs.1095.
4
Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.在患有尿潴留和前列腺良性增生或前列腺腺癌的患者中,组织学前列腺炎的意义。
BJU Int. 2012 Apr;109(8):1194-7. doi: 10.1111/j.1464-410X.2011.10527.x. Epub 2011 Aug 18.
5
Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk.良性前列腺增生和前列腺炎对前列腺癌风险的协同作用。
Br J Cancer. 2013 May 14;108(9):1778-83. doi: 10.1038/bjc.2013.184. Epub 2013 Apr 23.
6
Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.慢性前列腺炎与良性前列腺增生症的相关性:基于人群的全国队列研究。
World J Urol. 2024 Mar 9;42(1):126. doi: 10.1007/s00345-024-04820-w.
7
A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004.美国成年人勃起功能障碍患病率及前列腺疾病对勃起功能障碍影响的综合分析:来自2001 - 2004年美国国家健康和营养检查调查(NHANES)的证据
Front Endocrinol (Lausanne). 2025 Jan 13;15:1412369. doi: 10.3389/fendo.2024.1412369. eCollection 2024.
8
The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.良性前列腺增生中前列腺组织炎症对zeste同源物2核糖核酸表达增强子的影响。
Ann Saudi Med. 2012 May-Jun;32(3):262-8. doi: 10.5144/0256-4947.2012.262.
9
The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis.良性前列腺增生和前列腺炎重叠的下尿路症状。
Curr Opin Urol. 2006 Jan;16(1):5-10. doi: 10.1097/01.mou.0000193365.46081.cd.
10
Baseline Basal Cell Hyperplasia Is not Associated With Baseline Lower Urinary Tract Symptoms, Baseline Clinical Prostatitis or Prostate Cancer in Repeat Biopsies.基线基底细胞增生与基线下尿路症状、基线临床前列腺炎或重复活检中的前列腺癌无关。
Urology. 2019 Jul;129:160-164. doi: 10.1016/j.urology.2019.02.034. Epub 2019 Mar 23.

引用本文的文献

1
Immune cell single-cell RNA sequencing analyses link an age-associated T cell subset to symptomatic benign prostatic hyperplasia.免疫细胞单细胞RNA测序分析将一种与年龄相关的T细胞亚群与有症状的良性前列腺增生联系起来。
Front Immunol. 2025 Jul 7;16:1585446. doi: 10.3389/fimmu.2025.1585446. eCollection 2025.
2
CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis.CXCR4 通过改变糖酵解来调节巨噬细胞 M1 极化,从而促进前列腺纤维化。
Cell Commun Signal. 2024 Sep 26;22(1):456. doi: 10.1186/s12964-024-01828-y.
3
Autophagy in benign prostatic hyperplasia: insights and therapeutic potential.前列腺增生中的自噬:见解与治疗潜力。
BMC Urol. 2024 Sep 12;24(1):198. doi: 10.1186/s12894-024-01585-7.
4
Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study.慢性前列腺炎与良性前列腺增生症的相关性:基于人群的全国队列研究。
World J Urol. 2024 Mar 9;42(1):126. doi: 10.1007/s00345-024-04820-w.
5
Urologic complications in diabetes.糖尿病的泌尿系统并发症。
J Diabetes Complications. 2022 Oct;36(10):108288. doi: 10.1016/j.jdiacomp.2022.108288. Epub 2022 Aug 27.
6
Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score-matched analysis.良性前列腺增生进展的预测因素与中重度前列腺炎样症状之间的关联:一项倾向评分匹配分析。
Prostate Int. 2022 Jun;10(2):92-95. doi: 10.1016/j.prnil.2022.03.002. Epub 2022 Mar 11.
7
The Translational Role of Animal Models for Estrogen-Related Functional Bladder Outlet Obstruction and Prostatic Inflammation.动物模型在雌激素相关功能性膀胱出口梗阻和前列腺炎症中的转化作用
Vet Sci. 2022 Jan 31;9(2):60. doi: 10.3390/vetsci9020060.
8
Male Lower Urinary Tract Dysfunction: An Underrepresented Endpoint in Toxicology Research.男性下尿路功能障碍:毒理学研究中一个未得到充分关注的终点指标。
Toxics. 2022 Feb 16;10(2):89. doi: 10.3390/toxics10020089.
9
Serum interleukin 6 and acute urinary retention in elderly men with benign prostatic hyperplasia in China: a cross-sectional study.中国老年良性前列腺增生男性患者血清白细胞介素6与急性尿潴留:一项横断面研究
Transl Androl Urol. 2021 Jan;10(1):455-465. doi: 10.21037/tau-20-914.
10
Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis.前列腺炎、良性前列腺增生与前列腺癌之间的相关性:一项系统评价与Meta分析。
J Cancer. 2020 Jan 1;11(1):177-189. doi: 10.7150/jca.37235. eCollection 2020.

本文引用的文献

1
Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women.在一个种族和民族多样化的、以社区为基础的男性和女性人群中,不同泌尿系统症状复合体的重叠情况。
BJU Int. 2008 Jan;101(1):45-51. doi: 10.1111/j.1464-410X.2007.07191.x. Epub 2007 Sep 13.
2
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.前列腺炎症状与组织学炎症之间的关系研究:REDUCE化学预防试验的基线数据
J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. doi: 10.1016/j.juro.2007.05.041. Epub 2007 Jul 16.
3
Prostatitis.前列腺炎
J Urol. 2007 Jun;177(6):2050-7. doi: 10.1016/j.juro.2007.01.128.
4
Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?良性前列腺增生(BPH)是一种免疫炎症性疾病吗?
Eur Urol. 2007 May;51(5):1202-16. doi: 10.1016/j.eururo.2006.12.011. Epub 2006 Dec 11.
5
Prostatitis/chronic pelvic pain syndrome.前列腺炎/慢性盆腔疼痛综合征
Annu Rev Med. 2006;57:195-206. doi: 10.1146/annurev.med.57.011205.135654.
6
Sexually transmitted infections, prostatitis, ejaculation frequency, and the odds of lower urinary tract symptoms.性传播感染、前列腺炎、射精频率与下尿路症状的几率
Am J Epidemiol. 2005 Nov 1;162(9):898-906. doi: 10.1093/aje/kwi299. Epub 2005 Sep 21.
7
The three As of chronic prostatitis therapy: antibiotics, alpha-blockers and anti-inflammatories. What is the evidence?慢性前列腺炎治疗的三个A:抗生素、α受体阻滞剂和抗炎药。证据是什么?
BJU Int. 2004 Dec;94(9):1230-3. doi: 10.1111/j.1464-410X.2004.05148.x.
8
Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.良性前列腺增生中的慢性炎症与腺上皮中环氧化酶-2、Bcl-2的局部上调以及细胞增殖有关。
Prostate. 2004 Sep 15;61(1):60-72. doi: 10.1002/pros.20061.
9
Low agreement between previous physician diagnosed prostatitis and national institutes of health chronic prostatitis symptom index pain measures.既往医生诊断的前列腺炎与美国国立卫生研究院慢性前列腺炎症状指数疼痛测量结果之间的一致性较低。
J Urol. 2004 Jan;171(1):279-83. doi: 10.1097/01.ju.0000100088.70887.29.
10
Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.社区居住的黑人和白人男性下尿路症状严重程度及相关困扰的比较:奥姆斯特德县泌尿系统症状与健康状况研究及弗林特男性健康研究
Urology. 2003 Jun;61(6):1086-91. doi: 10.1016/s0090-4295(03)00154-7.